Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 390581 - 390600 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L04AG06) alemtuzumab (adm: P) | LEMTRADA 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION | 1 Vial, 1,2ml, 12 mg, Intravenous use, Concentrate for solution for infusion, 12mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | SanofiBelgium / BoehringerIngelheimPharmaGmbH&Co.KG |
| Saudi Arabia | (L04AG08) ocrelizumab (adm: P) | OCREVUS 30 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION | 1 Vial, 10ml, 300 mg, Intravenous use, Concentrate for solution for infusion, 300mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | F.Hoffmann-LaRocheLtd. / RocheDiagnosticsGmbH |
| Saudi Arabia | (L04AF03) upadacitinib (adm: O) | Rinvoq | 30 Bottle, 30 mg, Oral use, Prolonged-release tablet, 30mg , Bottle, Prolonged-release tablet | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ABBVIEDeutschlandGmbH / AbbVieIreland |
| Saudi Arabia | (L04AG03) natalizumab (adm: P) | Tysabri | 2 Pre-filled syringe, 1ml, 150 mg, Subcutaneous use, Solution for injection in pre-filled syringe, 150mg , Pre-filled syringe, Solution for injection in pre-filled syringe | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenIdecB.V-Natherland / VETTERPHARMA-FERTIGUNG,GMBH&CO.KG |
| Saudi Arabia | (L04AG05) vedolizumab (adm: P) | ENTYVIO | 2 Pre-filled syringe, 108 mg, Subcutaneous use, Solution for injection, 108mg , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TAKEDAPHARMAA/S / VetterPharma-FertigungGmbH&Co.KG |
| Saudi Arabia | (L04AG05) vedolizumab (adm: P) | ENTYVIO | 2 Pre-filled pen, 108 mg, Subcutaneous use, Solution for injection, 108mg , Pre-filled pen, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TAKEDAPHARMAA/S / VETTERPHARMA-FERTIGUNG,GMBH&CO.KG |
| Saudi Arabia | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300 mg powder for concentrate for solution for infusion | 1 Vial, 300 mg, Intravenous use, Powder for concentrate for solution for infusion, 300mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TAKEDAPHARMAA/S / HOSPIRA |
| Saudi Arabia | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | SAPHNELO 300 mg per 2 ml | 1 Vial, 2ml, 150 mg/ml, Intravenous use, Concentrate for solution for infusion, 150mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | AstraZenecaAB / AstraZenecaNijmegenB.V |
| Saudi Arabia | (L04AG12) ofatumumab (adm: P) | Kesimpta | 1 Pre-filled pen, 20 mg/ml, Subcutaneous use, Solution for injection in pre-filled pen, 20mg/ml , Pre-filled pen, Solution for injection in pre-filled pen | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NOVARTISPHARMASCHWEIZAG / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AK02) teriflunomide (adm: O) | Axyla | 28 Blister, 14 mg, Oral use, Film-coated tablet, 14mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / ShilpaMedicareLtd |
| Saudi Arabia | (L04AK02) teriflunomide (adm: O) | Myteb | 28 Blister, 14 mg, Oral use, Film-coated tablet, 14mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MedCityPharma / AizantDrugResearchSolutionsPvt.Ltd |
| Saudi Arabia | (L04AJ05) avacopan (adm: O) | Tavneos | 180 Bottle, 10 mg, Oral use, Capsule, hard, 10mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Microscopic Polyangiitis; Wegener Granulomatosis | ViforFreseniusMedicalCareRenalPharma / PatheonPharmaceuticalsInc. |
| Saudi Arabia | (L04AG13) teprotumumab | Tepezza | 1 Vial, 500 mg, Intravenous use, Intravenous infusion, 500mg , Vial, Intravenous infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | HorizonTherapeuticsDAC / CatalentIndianaLLCformerlyCookPharmicaLLC |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | Lenamid | 21 Blister, 10 mg, Oral use, Capsule, hard, 10mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SaudiAmarox / HeteroLabsLimitedUnit–V |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | Lenalidomide SPC | 21 Blister, 15 mg, Oral use, Capsule, hard, 15mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | Lenalidomide SPC | 21 Blister, 20 mg, Oral use, Capsule, hard, 20mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | Lenamid | 21 Blister, 25 mg, Oral use, Capsule, hard, 25mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SaudiAmarox / HeteroLabsLimitedUnit–III |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | Lenamid | 21 Blister, 5 mg, Oral use, Capsule, hard, 5mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SaudiAmarox / HeteroLabsLimitedUnit–V |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | LENALIDOMIDE SPC 10 mg Capsule | 21 Blister, 10 mg, Oral use, Capsule, hard, 10mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
| Saudi Arabia | (L04AX04) lenalidomide (adm: O) | LENALIDOMIDE SPC 25 mg Capsule | 21 Blister, 25 mg, Oral use, Capsule, hard, 25mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / SudairPharmaCompany |
Pages
